2171 — CARsgen Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$13.41bn
- HK$11.98bn
- CNY39.43m
Annual cashflow statement for CARsgen Therapeutics Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,064 | -4,737 | -891 | -747 | -798 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 715 | 4,155 | 125 | -24.9 | 240 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.2 | 16.9 | 41.7 | 230 | 68.9 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -295 | -512 | -643 | -455 | -410 |
| Capital Expenditures | -18.7 | -178 | -139 | -9.55 | -19.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 11.8 | -2,293 | 2,526 | 48.8 | 32.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.9 | -2,471 | 2,387 | 39.3 | 12.5 |
| Financing Cash Flow Items | 1,270 | -32.3 | -5.36 | -4.78 | -5.25 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,302 | 2,674 | -237 | -22.1 | 18.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 946 | -352 | 1,577 | -418 | -371 |